Percutaneous Coronary Intervention in the Patient on Oral Anticoagulation
Edited by Andrea Rubboli, Eric Eeckhout, and Gregory Lip
Author Information
Andrea Rubboli, Division of Cardiology and Cardiac Catheterization Laboratory, Ospedale Maggiore, Bologna, Italy,Eric Eeckhout, Division of Cardiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland,Gregory Lip, University of Birmingham, Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
Contributors:
Giancarlo Agnelli, MD
Division of Internal and Cardiovascular Medicine, and Stroke Unit
University of Perugia
Perugia, Italy
K. E. Juhani Airaksinen, MD, FESC
Heart Center,
Turku University Hospital,
Turku,
Finland
Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC
Division of Cardiology
VA Boston Healthcare System
Brigham and Women's Hospital
Boston, MA, USA
Thomas Cuisset, MD, PhD, FESC
Interventional Cardiology
Centre Hospitalier Universitaire Timone
Marseille, France
David P. Faxon, MD, FACC
Division of Cardiology
Brigham and Women's Hospital
Boston, MA, USA
Jonathan L. Halperin, MD, FACC, FAHA
The Zena and Michael A. Wiener Cardiovascular Institute
Mount Sinai Medical Center
New York, NY, USA
Gérard Helft, MD, PhD
Institute of Cardiology
Hôpital Pitié-Salpétrière
Paris, France
Kurt Huber, MD, FESC, FACC, FAHA
3rd Deparment of Internal Medicine and Emergency Medicine
Wilhelminenhospital
Vienna, Austria
Stefan K. James, MD, PhD
Department of Cardiology and Uppsala Clinical Research Center
Uppsala University
Uppsala, Sweden
Pasi P. Karjalainen, MD, PhD,
Heart Center,
Satakunta Central Hospital
Pori, Finland
Lars Hvilsted Rasmussen, MD, PhD, FESC
Thrombosis Research Unit
Aalborg University Hospital
Aalborg, Denmark
Axel Schlitt, MD
Paracelsus-Harz-Clinic Bad Suderode/
Medical Faculty
Martin Luther-University Halle-Wittenberg
Halle, Germany
Sam Schulman, MD
Thrombosis Service, McMaster Clinic
HHS - General Hospital
Hamilton, ON, Canada
Freek W. A. Verheugt, MD, FESC, FACC
Heartcenter
Onze Lieve Vrouwe Gasthuis (OLVG)
Amsterdam, Netherlands
Hôpital Pitié-Salpétrière
Paris, France
Kurt Huber, MD, FESC, FACC
3rd Department of Medicine, Cardiology, and Emergency Medicine
Wilhelminenspital
Wien, Austria
Stefan K. James, MD, PhD
Cardiology and Uppsala Clinical Research Center
Uppsala University
Uppsala, Sweden
Pasi P. Karjalainen, MD, PhD, FESC
Department of Cardiology
Satakunta Central Hospital
Pori, Finland
Lars Hvilsted Rasmussen, MD, PhD, FESC
Thrombosis Research Unit
Aalborg University Hospital
Aalborg, Denmark
Axel Schlitt, MD
Department of Internal Medicine III
Martin Luther-University Halle-Wittenberg
Halle, Germany
Sam Schulman, MD
Thrombosis Service, McMaster Clinic
HHS - General Hospital
Hamilton, ON, Canada
Freek W. A. Verheugt, MD, FESC, FACC
Heartcenter
Onze Lieve Vrouwe Gasthuis (OLVG)
Amsterdam, Netherlands